BioTD: an online database of biotoxins

Gaoang Wang,Hang Wu,Yang Liao,Zhen Chen,Qing Zhou,Wenxing Wang,Yifei Liu,Yilin Wang,Meijing Wu,Ruiqi Xiang,Yuntao Yu,Xi Zhou,Feng Zhu,Zhonghua Liu,Tingjun Hou
2024-12-28
Abstract:Biotoxins, mainly produced by venomous animals, plants and microorganisms, exhibit high physiological activity and unique effects such as lowering blood pressure and analgesia. A number of venom-derived drugs are already available on the market, with many more candidates currently undergoing clinical and laboratory studies. However, drug design resources related to biotoxins are insufficient, particularly a lack of accurate and extensive activity data. To fulfill this demand, we develop the Biotoxins Database (BioTD). BioTD is the largest open-source database for toxins, offering open access to 14,607 data records (8,185 activity records), covering 8,975 toxins sourced from 5,220 references and patents across over 900 species. The activity data in BioTD is categorized into five groups: Activity, Safety, Kinetics, Hemolysis and other physiological indicators. Moreover, BioTD provides data on 986 mutants, refines the whole sequence and signal peptide sequences of toxins, and annotates disulfide bond information. Given the importance of biotoxins and their associated data, this new database was expected to attract broad interests from diverse research fields in drug discovery. BioTD is freely accessible at <a class="link-external link-http" href="http://biotoxin.net/" rel="external noopener nofollow">this http URL</a>.
Biomolecules
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the current shortage of resources for biotoxin - related drug design, especially the lack of accurate and extensive activity data. Specifically: 1. **Limitations of existing databases**: Although some existing databases such as Uniprot, ChEMBL, PDB, and DrugBank provide information on peptide sequences, functions, and structural models related to biotoxins, these databases do not provide comprehensive and systematic data specifically for biotoxins, especially experimentally - verified activity information. 2. **Requirements for drug development**: Since biotoxins have unique physiological activities and therapeutic effects (such as lowering blood pressure and relieving pain), they are of great value in drug development. Many venom - based drugs are already on the market, and more candidate drugs are in the clinical or laboratory research stage. Therefore, a specialized database is needed to support these research efforts. To solve the above problems, the authors developed the "Biotoxin Database" (BioTD). BioTD is an open - source and the largest biotoxin database, aiming to provide the following improvements: - **Extensive data coverage**: It contains 14,607 data records of 8,975 toxins from more than 900 species, of which 8,185 are activity records. - **Detailed activity classification**: The activity data is divided into five categories: activity (such as effective concentration/dose, inhibitory concentration), safety (such as lethal concentration/dose, therapeutic index), kinetics (such as Kd, Ki, Kact, Tau (off)), hemolysis, and other physiological indicators. - **Mutant information**: It includes information on 986 mutants, which is helpful for understanding the structure - activity relationship (SAR). - **Sequence refinement**: It distinguishes between the full - length sequence and the signal peptide sequence of toxins and labels the disulfide bond information. - **3D structure visualization**: It provides 3D structure visualization of all toxins, of which 1,753 structures are from PDB, and the remaining 7,222 are predicted by AlphaFold. Through these improvements, BioTD is expected to become an important resource for biotoxin research and new drug development.